Holen Sie sich die Stockscreener-App
7.63
1.91%
0.29
Handel nachbörslich:
7.78
0.15
+1.97%
Schlusskurs vom Vortag:
$7.34
Offen:
$7.27
24-Stunden-Volumen:
13,089
Relative Volume:
0.16
Marktkapitalisierung:
$91.83M
Einnahmen:
$2.09M
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-11.39
EPS:
-0.67
Netto-Cashflow:
$-3.64M
1W Leistung:
-4.59%
1M Leistung:
+4.62%
6M Leistung:
+50.81%
1J Leistung:
-7.54%
1-Tages-Spanne:
$7.16
$7.7261
1-Wochen-Bereich:
$7.02
$8.6259
52-Wochen-Spanne:
$3.7223
$11.78
Nutriband Inc Stock (NTRB) Company Profile
Firmenname
Nutriband Inc
Sektor
Branche
Telefon
407 377-6695
Adresse
121 S. ORANGE AVE., ORLANDO
Vergleichen Sie NTRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
7.63 | 88.20M | 2.09M | -5.28M | -3.64M | -0.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-22 | Eingeleitet | Noble Capital Markets | Outperform |
Nutriband Inc Aktie (NTRB) Neueste Nachrichten
Real time breakdown of Nutriband Inc. Equity Warrant stock performanceJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Using portfolio simulators with Nutriband Inc. includedQuarterly Portfolio Review & Reliable Entry Point Alerts - newser.com
How Nutriband Inc. stock benefits from tech adoptionQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
Backtesting results for Nutriband Inc. Equity Warrant trading strategiesJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Can Nutriband Inc. Equity Warrant stock beat analyst upgrades2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
What momentum indicators show for Nutriband Inc. Equity Warrant stockWeekly Gains Report & Community Consensus Trade Alerts - newser.com
Is Nutriband Inc. Equity Warrant stock safe for conservative investors2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Ranking Nutriband Inc. Equity Warrant among high performing stocks via toolsJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Applying big data sentiment scoring on Nutriband Inc.July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Can machine learning forecast Nutriband Inc. Equity Warrant recoveryJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
Sentiment analysis tools applied to Nutriband Inc.Portfolio Profit Report & Free Community Consensus Stock Picks - newser.com
What analysts say about Nutriband Inc Equity Warrant stockBullish Engulfing Patterns & Free Stock Trading Workshops - earlytimes.in
How sustainable is Nutriband Inc. stock dividend payoutJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
Nutriband (NASDAQ: NTRB) Partners with Brand Institute to Develop Global Brand Identity for AVERSA FENTANYL - Digital Journal
What Fibonacci levels say about Nutriband Inc. Equity Warrant reboundJuly 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Nutriband Partners with Brand Institute to Develop Global Brand Identity for Abuse-Deterrent Fentanyl Patch - citybuzz
Is Nutriband Inc. Equity Warrant stock a buy before product launches2025 Price Action Summary & Breakout Confirmation Alerts - newser.com
Nutriband's (NTRB) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Nutriband (NTRB) Partners with Brand Institute for Product Branding - GuruFocus
Nutriband partners with Brand Institute to develop name for opioid patch - Investing.com
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - The Manila Times
Nutriband Initiates Global Brand Development for Abuse Deterrent Fentanyl Patch in Partnership with Brand Institute - Quiver Quantitative
Will Nutriband Inc. Equity Warrant stock recover after recent dropGap Down & Long-Term Investment Growth Plans - newser.com
Trend analysis for Nutriband Inc. Equity Warrant this weekTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Long term hold vs stop loss in Nutriband Inc.2025 Stock Rankings & AI Enhanced Execution Alerts - newser.com
Signal strength of Nutriband Inc. stock in tech scannersPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Sector ETF performance correlation with Nutriband Inc.Share Buyback & Stock Portfolio Risk Management - newser.com
Nutriband (NASDAQ: NTRB) Files Provisional Patent to Strengthen Protection of AVERSA(TM) Abuse-Deterrent Technology - Digital Journal
About Us - FinancialContent
What Fibonacci levels say about Nutriband Inc. reboundPortfolio Value Summary & Expert Approved Momentum Ideas - newser.com
What MACD and RSI say about Nutriband Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
How to escape a deep drawdown in Nutriband Inc.Sell Signal & Growth Focused Entry Reports - newser.com
Nutriband to Present at Emerging Growth Conference, Highlighting Abuse-Deterrent Transdermal Technology - citybuzz
Nutriband (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference - Digital Journal
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology - GlobeNewswire
Nutriband files patent to enhance abuse deterrent patch technology - Investing.com
Nutriband files patent to enhance abuse deterrent patch technology By Investing.com - Investing.com Australia
Nutriband Inc. Files Provisional Patent Application to Enhance AVERSA™ Abuse Deterrent Technology for Opioid and Stimulant Patches - Quiver Quantitative
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference - GlobeNewswire
Finanzdaten der Nutriband Inc-Aktie (NTRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):